Cover - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2023 |
Mar. 15, 2024 |
Jun. 30, 2023 |
|
| Cover [Abstract] | |||
| Document Type | 10-K/A | ||
| Amendment Flag | true | ||
| Amendment Description | ProPhase Labs, Inc.. (the “Company,” “ProPhase,” “we,” “us” or “our”) is filing this Amendment No. 1 on Form 10-K/A (this “Amendment”) to amend our Annual Report on Form 10-K for the year ended December 31, 2023, originally filed with the Securities and Exchange Commission (the “SEC”) on March 29, 2024 (the “Original 10-K”), to (i) include the information required by Items 10 through 14 of Part III of Form 10-K and (ii) amend Item 15 of Part IV of the Original 10-K to update the exhibit list. The information required by Items 10 through 14 of Part III of Form 10-K was previously omitted from the Original 10-K in reliance on General Instruction G(3) to Form 10-K, which permits the information in the above referenced items to be incorporated in the Form 10-K by reference from our definitive proxy statement if such statement is filed no later than 120 days after our fiscal year-end. We are filing this Amendment to include Part III information in our Form 10-K because a definitive proxy statement containing such information will not be filed by us within 120 days after the end of the fiscal year covered by the Form 10-K. | ||
| Document Annual Report | true | ||
| Document Transition Report | false | ||
| Document Period End Date | Dec. 31, 2023 | ||
| Document Fiscal Period Focus | FY | ||
| Document Fiscal Year Focus | 2023 | ||
| Current Fiscal Year End Date | --12-31 | ||
| Entity File Number | 000-21617 | ||
| Entity Registrant Name | ProPhase Labs, Inc. | ||
| Entity Central Index Key | 0000868278 | ||
| Entity Tax Identification Number | 23-2577138 | ||
| Entity Incorporation, State or Country Code | DE | ||
| Entity Address, Address Line One | 711 Stewart Avenue | ||
| Entity Address, Address Line Two | Suite 200 | ||
| Entity Address, City or Town | Garden City | ||
| Entity Address, State or Province | NY | ||
| Entity Address, Postal Zip Code | 11530 | ||
| City Area Code | (215) | ||
| Local Phone Number | 345-0919 | ||
| Title of 12(b) Security | Common Stock, $0.0005 par value per share | ||
| Trading Symbol | PRPH | ||
| Security Exchange Name | NASDAQ | ||
| Entity Well-known Seasoned Issuer | No | ||
| Entity Voluntary Filers | No | ||
| Entity Current Reporting Status | Yes | ||
| Entity Interactive Data Current | Yes | ||
| Entity Filer Category | Accelerated Filer | ||
| Entity Small Business | true | ||
| Entity Emerging Growth Company | false | ||
| Entity Shell Company | false | ||
| Entity Public Float | $ 100,240,301 | ||
| Entity Common Stock, Shares Outstanding | 18,045,209 | ||
| Documents Incorporated by Reference [Text Block] | None | ||
| ICFR Auditor Attestation Flag | true | ||
| Document Financial Statement Error Correction [Flag] | false | ||
| Auditor Firm ID | 536 | ||
| Auditor Name | Morison Cogen LLP | ||
| Auditor Location | Blue Bell, Pennsylvania |